Glutamatergic Dysfunction
Glutamatergic Dysfunction is a pathophysiological construct in neuropharmacology denoting an aberration in glutamatergic neurotransmission characterized by disrupted synaptic signaling, receptor desensitization, or excitotoxic mechanisms that deviate from normative glutamatergic function.
1.6K
Publications
114.8K
Citations
8.8K
Authors
1.9K
Institutions
Publications per year
2017–2026
437
Parents
1.6K
Glutamate neurotoxicity and diseases of the nervous system
Dennis W. Choi · Neuron · 1988 · 8K citations
Epilepsy and Exacerbation of Brain Injury in Mice Lacking the Glutamate Transporter GLT-1
Kohichi Tanaka, Kei Watase, Toshiya Manabe et al. · Science · 1997 · 1.8K citations
1–5 of 1.6K
8.8K
15
h-index
13
h-index
Icahn School of Medicine at Mount Sinai, United States
11 publications · 1.2K citations
11
h-index
11
h-index
10
h-index
1–5 of 8.8K
1.9K

Johns Hopkins University
Baltimore, United States
33 h-index
216 publications
24.4K citations
Harvard University
Cambridge, United States
30 h-index
157 publications
14.6K citations
Inserm
Paris, France
28 h-index
200 publications
16.1K citations

Icahn School of Medicine at Mount Sinai
New York, United States
27 h-index
83 publications
7.7K citations
King's College London
London, United Kingdom
25 h-index
176 publications
14.5K citations
Yale University
New Haven, United States
23 h-index
118 publications
15.3K citations

Johns Hopkins Medicine
Baltimore, United States
22 h-index
136 publications
18.1K citations

Centre National de la Recherche Scientifique
Paris, France
21 h-index
122 publications
7.3K citations
1–8 of 1.9K
36 publications · 3.5K citations
32
h-index
54 publications · 3.3K citations
28
h-index
Repository · 43 publications · 2.7K citations
27
h-index
31 publications · 2.1K citations
26
h-index
JNC · 23 publications · 2.1K citations
22
h-index
1–5